Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial.




Perera KS, Ng KKH, Nayar S1, Catanese L, Dyal L, Sharma M, Connolly SJ, Yusuf S, Bosch J, Eikelboom JW, Hart RG.

2020

JAMA Neurology

77

1

6

2168-6149

DOIhttps://doi.org/10.1001/jamaneurol.2019.2984




Last updated on 2024-26-11 at 13:40